1. Home
  2. ARWR vs SA Comparison

ARWR vs SA Comparison

Compare ARWR & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • SA
  • Stock Information
  • Founded
  • ARWR 2003
  • SA 1979
  • Country
  • ARWR United States
  • SA Canada
  • Employees
  • ARWR N/A
  • SA N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • SA Precious Metals
  • Sector
  • ARWR Health Care
  • SA Basic Materials
  • Exchange
  • ARWR Nasdaq
  • SA Nasdaq
  • Market Cap
  • ARWR 1.8B
  • SA 1.6B
  • IPO Year
  • ARWR 1993
  • SA N/A
  • Fundamental
  • Price
  • ARWR $16.29
  • SA $16.80
  • Analyst Decision
  • ARWR Buy
  • SA
  • Analyst Count
  • ARWR 8
  • SA 0
  • Target Price
  • ARWR $43.71
  • SA N/A
  • AVG Volume (30 Days)
  • ARWR 2.0M
  • SA 593.1K
  • Earning Date
  • ARWR 08-07-2025
  • SA 08-12-2025
  • Dividend Yield
  • ARWR N/A
  • SA N/A
  • EPS Growth
  • ARWR N/A
  • SA N/A
  • EPS
  • ARWR N/A
  • SA N/A
  • Revenue
  • ARWR $545,209,000.00
  • SA N/A
  • Revenue This Year
  • ARWR $22,384.93
  • SA N/A
  • Revenue Next Year
  • ARWR N/A
  • SA N/A
  • P/E Ratio
  • ARWR N/A
  • SA N/A
  • Revenue Growth
  • ARWR 1436.97
  • SA N/A
  • 52 Week Low
  • ARWR $9.57
  • SA $9.40
  • 52 Week High
  • ARWR $27.34
  • SA $20.55
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 49.29
  • SA 64.72
  • Support Level
  • ARWR $15.83
  • SA $15.11
  • Resistance Level
  • ARWR $16.73
  • SA $17.14
  • Average True Range (ATR)
  • ARWR 0.87
  • SA 0.50
  • MACD
  • ARWR -0.02
  • SA 0.00
  • Stochastic Oscillator
  • ARWR 73.75
  • SA 83.25

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

Share on Social Networks: